ArticleMedical image analysis2026
Report Supervision.
Article in Medical image analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Segmentation models can surpass radiologists, classification models, and vision-language models in tumor detection. Furthermore, segmentation models outline tumors, allowing radiologists to better verify and trust the AI output. However, their main limitation is the scarcity of tumor masks: creating one 3D tumor mask takes up to 30 min, so most public CT datasets contain only a few hundred masks, and even the largest private datasets contain only a couple of thousand. Tumor masks are not produced in clinical routine, but radiology reports are. Public datasets contain tens of thousands of CT-Report pairs, and hospitals contain hundreds of thousands. These reports describe tumors in detail, providing large-scale, informative training data. Here, we introduce Report Supervision (R-Super), a training framework that uses reports to directly supervise and improve tumor segmentation. R-Super introduces new loss functions that teach segmentation models to segment tumors that match report descriptions of tumor count, sizes, and locations. Reports are only used for training. We evaluated R-Super on kidney and pancreatic tumor segmentation, exploring diverse training data sizes, up to 41,418 CT-Report pairs plus 3488 CT-Mask pairs. On external validation, R-Super increased tumor detection F1-Score and segmentation DSC by up to +15% with respect to mask-only training. It also surpassed alternative methods such as CLIP and multi-task learning. It enabled pancreatic tumor detection on non-contrast CT without requiring tumor masks from non-contrast CT. In summary, by leveraging numerous readily available reports to supplement scarce masks, R-Super strongly improves AI performance when very few training masks are available (e.g., 50), and when many masks are available (e.g., 3488), unlocking scale in tumor segmentation. Project: https://github.com/MrGiovanni/R-Super.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.